Walgreens Boots Alliance is going private at $11.45/share plus up to $3 via a CVR, offering a potential $14.45 payout. See ...

Key Points Walgreens is an iconic brand in the pharmacy space, but it has fallen on hard times.The retailer has agreed to be ...

The transaction, expected to close in Q3 or Q4, will take the company private after nearly 100 years as a public company.

Shareholders for Walgreens Boots Alliance overwhelmingly voted to approve the company’s sale to Sycamore Partners, with 96% of shareholders at a special meeting voting to green-light the merger, ...

Boots, the high street staple and Nottinghamshire's largest business, will soon have new owners after a $10 billion deal was ...

Retail Gazette takes a closer look at Boots' new private equity owner and what the deal means for the future of the health ...

Walgreens Boots Alliance shareholders approved the company’s sale to private equity firm Sycamore Partners at a July 11 special meeting. Walgreens announced in March that it had entered into a ...

This would represent the third attempted sale of Boots since 2022. WBA previously sought a £7bn sale but withdrew after ...

By overwhelmingly approving the $10 billion sale to private-equity firm Sycamore Partners, investors set an official end date on Walgreens’ run as one of Chicago’s most iconic public companies ...

A $10bn (£7.4bn) takeover of Walgreens Boots Alliance (WBA) by Sycamore Partners has been officially approved, with 96% of ...

Walgreens Boots Alliance reported adjusted earnings per share of 38 cents for the third quarter of its 2025 fiscal year, which beat Zacks Investment Research's estimate of 34 cents per share.

Walgreens’ third-quarter performance comes ahead of its $10 billion sale to private equity firm Sycamore Partners, expected to close by the end of 2025. The looming transaction has created ...